HIV Epidemiology
The Latest
Researchers Discuss the Lessons of the HIV Vaccine Trial That Terminated Earlier This Year
HVTN 702 may not have proven an effective vaccine, but scientists still learned from the research.
CROI 2020: What to Expect in HIV Science From This Year’s Conference
COVID-19 will impact both the program content and attendees this year, but there are still important HIV science presentations.
One-Two Punch of Antibodies and Antiretrovirals Stops HIV Infection in Primate Infants
While it is too soon to tell, this research involving broadly neutralizing antibodies could point to new methods for preventing vertical transmission.
Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work
Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.
This Week in HIV Research: The Long Road to the End
Dec. 12, 2019: A lot of catchup to do before “Ending the HIV Epidemic”; the value of online HIV self-test distribution; viral suppression is about more than basic HIV treatment services; effect of hormone therapy on PrEP levels.
Black Gay Men in the Ballroom Scene Experience a Unique Form of HIV Prevention
Though not as widely studied, there are many ways that men who belong to the gay family networks of the ballroom scene may be getting an HIV intervention.
Do Intimate Relationships Affect Drug Use in Black Gay and Bisexual Men?
Men with a main partner used drugs during sex at similar rates to those with only casual partners. But studying couples could lead to HIV prevention programs that could reduce racial disparity.
Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.
Pre-exposure prophylaxis (PrEP) is a vital part of ending HIV, but ads targeting people to join lawsuits are planting needless fears in patients, three leading HIV specialists write.
This Week in HIV Research: Today's Prescription Courtesy of Dr. Robot
Oct. 24, 2019: A computerized antiretroviral recommendation tool; higher Fiebig stage equals more frequent viral load blips; low prescription refill rates among Americans starting treatment; internalized stigma and HIV outcomes.
Trans Women Are Increasingly A Focus of HIV Programs, But What About their Cisgender Male Partners?
This population is under-represented in HIV data, and few prevention or treatment interventions exist to support them. A new meta-analysis hopes to paint a picture of what's needed.